Compare Guardant Health Inc. Common Stock (GH) vs KKR & Co Inc (KKR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs KKR & Co Inc — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while KKR & Co Inc trades at $89.56 (market cap $80.49B). The key difference: KKR & Co Inc is far larger — about 3.6× Guardant Health Inc. Common Stock's market cap, and KKR & Co Inc pays a 0.87% dividend while Guardant Health Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and KKR & Co Inc for 67 Days on average.
| GH | KKR | |
|---|---|---|
Market Cap | $22.58B | $80.49B |
Volume | 2,200,599 | 4,571,222 |
Sector | Health | Financials |
52-Week High | $187.22 | $142.75 |
52-Week Low | $61.73 | $83.88 |
Typical Hold Time | 0 Days | 67 Days |
Enterprise Value | $23.22B | $3.05B |
Dividend Yield | — | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KKR trades at $89.56, down 1.22% on the day, amid a bearish technical signal but strong analyst support with a consensus price target of $123.30. Recent earnings show beats in Q1 and Q2 2026, with revenue at $19.21B in 2025 and net income of $2.37B. The company is active in strategic deals, including a joint venture with Thomson Reuters and investments in AI infrastructure, signaling growth initiatives. Cash flow trends show improved operational performance in 2025, with net cash flow turning positive at $1.78B.
The outlook for KKR is positive based on fundamental strength and analyst optimism, with 88.9% buy ratings. Risks include market volatility and execution of recent investments, but the stock presents a potential upside of over 37% to the consensus target. Investors should weigh strong profitability metrics against technical bearish signals for near-term entry points.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About KKR & Co Inc
KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Read more on KKR →
